학술논문

Availability, coverage, and scope of health information systems for kidney care across world countries and regions.
Document Type
article
Source
Nephrology Dialysis Transplantation. 37(1)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Health Services
Clinical Research
Patient Safety
Prevention
Kidney Disease
Health and social care services research
8.1 Organisation and delivery of services
Renal and urogenital
Good Health and Well Being
Cross-Sectional Studies
Developing Countries
Health Information Systems
Humans
Kidney
Renal Insufficiency
Chronic
chronic kidney disease
end-stage kidney disease
health information systems
kidney replacement therapy
registries
Urology & Nephrology
Clinical sciences
Language
Abstract
BackgroundHealth information systems (HIS) are fundamental tools for the surveillance of health services, estimation of disease burden and prioritization of health resources. Several gaps in the availability of HIS for kidney disease were highlighted by the first iteration of the Global Kidney Health Atlas.MethodsAs part of its second iteration, the International Society of Nephrology conducted a cross-sectional global survey between July and October 2018 to explore the coverage and scope of HIS for kidney disease, with a focus on kidney replacement therapy (KRT).ResultsOut of a total of 182 invited countries, 154 countries responded to questions on HIS (85% response rate). KRT registries were available in almost all high-income countries, but few low-income countries, while registries for non-dialysis chronic kidney disease (CKD) or acute kidney injury (AKI) were rare. Registries in high-income countries tended to be national, in contrast to registries in low-income countries, which often operated at local or regional levels. Although cause of end-stage kidney disease, modality of KRT and source of kidney transplant donors were frequently reported, few countries collected data on patient-reported outcome measures and only half of low-income countries recorded process-based measures. Almost no countries had programs to detect AKI and practices to identify CKD-targeted individuals with diabetes, hypertension and cardiovascular disease, rather than members of high-risk ethnic groups.ConclusionsThese findings confirm significant heterogeneity in the global availability of HIS for kidney disease and highlight important gaps in their coverage and scope, especially in low-income countries and across the domains of AKI, non-dialysis CKD, patient-reported outcomes, process-based measures and quality indicators for KRT service delivery.